Aziz Mottiwala - Net Worth and Insider Trading

Aziz Mottiwala Net Worth

The estimated net worth of Aziz Mottiwala is at least $3 Million dollars as of 2025-05-05. Aziz Mottiwala is the Chief Commercial Officer of Tarsus Pharmaceuticals Inc and owns about 65,057 shares of Tarsus Pharmaceuticals Inc (TARS) stock worth over $3 Million. Details can be seen in Aziz Mottiwala's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aziz Mottiwala has not made any transactions after 2025-03-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Aziz Mottiwala

To

Aziz Mottiwala Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Aziz Mottiwala owns 2 companies in total, including Tarsus Pharmaceuticals Inc (TARS) , and Opiant Pharmaceuticals Inc (OPNT) .

Click here to see the complete history of Aziz Mottiwala’s form 4 insider trades.

Insider Ownership Summary of Aziz Mottiwala

Ticker Company Transaction Date Type of Owner
TARS Tarsus Pharmaceuticals Inc 2025-03-20 Chief Commercial Officer
OPNT Opiant Pharmaceuticals Inc 2019-09-20 Chief Commercial Officer

Aziz Mottiwala Latest Holdings Summary

Aziz Mottiwala currently owns a total of 1 stock. Aziz Mottiwala owns 65,057 shares of Tarsus Pharmaceuticals Inc (TARS) as of March 20, 2025, with a value of $3 Million.

Latest Holdings of Aziz Mottiwala

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TARS Tarsus Pharmaceuticals Inc 2025-03-20 65,057 47.36 3,081,100

Holding Weightings of Aziz Mottiwala


Aziz Mottiwala Form 4 Trading Tracker

According to the SEC Form 4 filings, Aziz Mottiwala has made a total of 13 transactions in Tarsus Pharmaceuticals Inc (TARS) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Tarsus Pharmaceuticals Inc is the sale of 10,565 shares on March 20, 2025, which brought Aziz Mottiwala around $505,852.

Insider Trading History of Aziz Mottiwala

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Aziz Mottiwala Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Aziz Mottiwala Ownership Network

Ownership Network List of Aziz Mottiwala

No Data

Ownership Network Relation of Aziz Mottiwala

Insider Network Chart


Aziz Mottiwala Owned Company Details

What does Tarsus Pharmaceuticals Inc do?

Who are the key executives at Tarsus Pharmaceuticals Inc?

Aziz Mottiwala is the Chief Commercial Officer of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include director & 10 percent owner & President and CEO Bobak R. Azamian , Chief Human Resources Officer Dianne C. Whitfield , and General Counsel Bryan Wahl .

Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary

Over the past 18 months, Aziz Mottiwala made 2 insider transaction in Tarsus Pharmaceuticals Inc (TARS) with a net sale of 15,331. Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 96,631 shares made by Bobak R. Azamian , a net sale of 22,478 shares made by Bryan Wahl , and a net sale of 19,380 shares made by Dianne C. Whitfield .

In summary, during the past 3 months, insiders sold 68,485 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 68,485 shares. During the past 18 months, 217,703 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 1,000 shares were bought by its insiders, resulting in a net sale of 216,703 shares.

Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tarsus Pharmaceuticals Inc Insider Transactions

No Available Data

Aziz Mottiwala Mailing Address

Above is the net worth, insider trading, and ownership report for Aziz Mottiwala. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Aziz Mottiwala's mailing address is: Santa Monica Ca 90401.